Entero Healthcare Solutions Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 18, 2025.
ENTERO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Entero Healthcare Solutions has submitted its Annual Report for FY 2024-25 and the Notice for its 7th AGM to be held on September 18, 2025 at 11:30 AM via video conferencing. The company reported consolidated revenue of ₹5,096 crore, up 30% year-on-year, far ahead of the Indian pharmaceutical market growth of 8%. Profit after tax jumped 170% to ₹107 crore, while EBITDA grew 53% to ₹172 crore with margin expanding to 3.4% from 2.9%. The company completed 10 strategic acquisitions adding ₹792 crore in annualized revenue, expanded its reach to 500 districts, 95,300+ retail chemists and 3,600+ hospitals, and turned operating cash flow positive in the second half of the year. ROCE improved to 10.73% and ROE rose to 7.71%, while the company moved to a net cash position.
This is a routine AGM notice and annual report filing with no immediate stock-moving action expected. However, the strong FY25 results — 30% revenue growth, 170% PAT growth, margin expansion, and a shift to net cash — reinforce the post-IPO growth story and may support positive sentiment heading into the AGM.